The State of US Healthcare Policy With a Split Congress

With a “red wave” failing to materialize at the end of the mid-term election season in the US, it looks increasingly likely that Congress will be split with Democrats controlling the Senate and Republicans controlling the House of Representatives. This portends a significant change in policy-making, as many of the Democrats’ plans for healthcare, such as drug pricing reform and Medicare expansion, may be dead on arrival.

According to Robert King, “Republicans could use their oversight tools to scrutinize the implementation of the Inflation Reduction Act that gave Medicare the power to negotiate for lower drug prices for a small subset of Medicare Part B drugs, said Joel White, CEO of consulting firm Horizon Government Affairs and a former hill staffer.”

To read more, click here.

(Source: Fierce Healthcare, November 8^th, 2022)